CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Vaccine

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(98)80122-9PMID 9682382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Applied antisense oligonucleotide technology

  1998cited by this paper
• Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.

  1998cited by this paper
• CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

  1998cited by this paper
• Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma

  1998cited by this paper
• Current options for vaccine delivery systems by mucosal routes

  1997cited by this paper
• Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12

  1997cited by this paper
• Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12.

  1997cited by this paper
• Adjuvants--a classification and review of their modes of action.

  1997cited by this paper
• Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.

  1997cited by this paper
• Mucosal Immune Response to an HIV C4/V3 Peptide Following Nasal or Intestinal Immunization of Rabbits

  1997cited by this paper
• Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA Responses

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants

  1997cited by this paper
• CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

  1997cited by this paper
• Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

  1996cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.

  1996cited by this paper
• Antisense oligonucleotides: towards clinical trials.

  1996cited by this paper
• Activation of human B cells by phosphorothioate oligodeoxynucleotides.

  1996cited by this paper
• Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.

  1996cited by this paper
• Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge

  1996cited by this paper
• Macrophages ingest and are activated by bacterial DNA.

  1996cited by this paper
• CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

  1996cited by this paper
• An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

  1996cited by this paper
• Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

  1996cited by this paper
• Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.

  1996cited by this paper
• Amplification of antibody production by phosphorothioate oligodeoxynucleotides.

  1996cited by this paper
• Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-α

  1996cited by this paper
• Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.

  1995cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal Administration

  1994cited by this paper
• Oral immunization with influenza virus in biodegradable microspheres.

  1993cited by this paper
• Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides

  1993cited by this paper
• DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth

  1992cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

  1992cited by this paper
• Uptake of Oligodeoxyribonucleotides by Lymphoid Cells Is Heterogeneous and Inducible

  1991cited by this paper
• Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

  1991cited by this paper
• In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.

  1990cited by this paper
• The common mucosal immune system and current strategies for induction of immune responses in external secretions

  1987cited by this paper
• CpG-rich islands and the function of DNA methylation

  1986cited by this paper
• Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

  1984cited by this paper
• The removal of non-specific inhibitors from human and animal sera to mumps and para-influenza type I viruses by kaolin.

  1966cited by this paper

• Adjuvantation of Kyasanur Forest Disease vaccine with TLR9 agonist CpG adjuvant enhances immunological efficacy and potency of the vaccine

  2025influential citation
• The immune memory of innate immune systems.

  2024cites this paper
• A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine

  2023cites this paper
• Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine

  2023cites this paper
• Production and Evaluation of Chicken Egg Yolk Immunoglobulin (IgY) against Human and Simian Rotaviruses

  2022cites this paper
• Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act.

  2021cites this paper
• Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.

  2021cites this paper
• Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Porphyromonas gingivalis

  2021cites this paper
• DNA Vaccines: Methods and Protocols

  2021cites this paper
• Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses

  2021cites this paper
• Intranasal vaccine: factors to consider in research and development.

  2021cites this paper
• Mucosal Vaccines for Aged: Challenges and Struggles in Immunosenescence

  2020cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• CpG Oligonucleotides as Vaccine Adjuvants.

  2020cites this paper
• Evaluating the innate immune response of the porcine uterus to vaccine adjuvants for the development of an intrauterine vaccine

  2019cites this paper
• Mucosal Vaccination Challenges in Aging: Understanding Immunosenescence in the Aerodigestive Tract

  2019cites this paper
• CpG enhances the immunogenicity of heterologous DNA-prime/protein-boost vaccination with the heavy chain myosin of Brugia malayi in BALB/c mice

  2019cites this paper
• Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

  2019cites this paper
• A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge

  2018cites this paper
• Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.

  2018cites this paper
• The protective effects of nasal PcrV‐CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia

  2018cites this paper
• IMMUNOPROTECTIVE MECHANISMS ASSOCIATED WITH IN OVO DELIVERY OF OLIGODEOXYNUCLEOTIDES CONTAINING CpG MOTIFS (CpG-ODN) AND FORMULATION OF CpG WITH NANOPARTICLES TO ENHANCE ITS EFFICACY IN NEONATAL BROILER CHICKENS

  2018cites this paper
• Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants

  2018cites this paper
• Nucleic Acids as Adjuvants

  2018cites this paper
• DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination

  2018cites this paper
• 31 – Inactivated Influenza Vaccines

  2018cites this paper
• Dendritic cell‐targeting DNA‐based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae

  2017cites this paper
• Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model.

  2017cites this paper
• Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens

  2017influential citation
• A plasmid containing CpG ODN as vaccine adjuvant against grass carp reovirus in grass carp Ctenopharyngodon idella

  2017cites this paper
• TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION

  2017cites this paper
• A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.

  2016cites this paper
• Promotion of Nickel (Ni) Allergy by Anamnestic Sensitization with a Bacterial Component, Lipopolysaccharide (LPS), in Mice

  2016influential citation
• The Challenge of Inducing Vaccine Protection in the Elderly

  2016cites this paper
• Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections

  2016cites this paper
• Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination

  2016cites this paper
• Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.

  2015cites this paper
• Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag

  2015cites this paper
• Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles

  2015cites this paper
• Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant.

  2015cites this paper
• Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells

  2015cites this paper
• Detecção de rotavírus do grupo A em amostras fecaisadaptação do teste de aglutinação em látex para o emprego de anticorpos IgY anti-Rotavírus A

  2014cites this paper
• Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

  2014cites this paper
• Die Interaktion der plasmazytoiden dendritischen Zelle mit dem CD8+ T-Lymphozyten

  2014cites this paper
• Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.

  2014cites this paper
• monocytogenes Listeria Intraperitoneal Challenge with Virulent Reduces Susceptibility to Oral or Oral Pretreatment of Mice with CpG DNA

  2014cites this paper
• 17 – Inactivated influenza vaccines

  2013cites this paper
• Exploiting the respiratory syncytial virus (RSV) fusion protein to potentiate the immune response to influenza virus

  2013cites this paper
• Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

  2013cites this paper
• A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

  2013cites this paper
• Adjuvants in Primates CpG Oligodeoxynucleotides as Vaccine

  2013cites this paper
• A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis

  2013cites this paper
• A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

  2012cites this paper
• Mucosal Adjuvanticity of Fibronectin-Binding Peptide (FBP) Fused with Echinococcus multilocularis Tetraspanin 3: Systemic and Local Antibody Responses

  2012cites this paper
• Nucleic acid adjuvants: toward an educated vaccine.

  2012cites this paper
• Adjuvants for Leishmania vaccines: from models to clinical application

  2012cites this paper
• Plasmid DNA containing multiple CpG motifs triggers a strong immune response to hepatitis B surface antigen when combined with incomplete Freund's adjuvant but not aluminum hydroxide.

  2012cites this paper
• Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate.

  2012cites this paper
• Strategies for intranasal delivery of vaccines

  2012cites this paper
• CpG underrepresentation and the bacterial CpG-specific DNA methyltransferase M.MpeI

  2012cites this paper
• The development of an effective vaccine against Chlamydia : utilisation of a non-toxic mucosal adjuvant to generate a protective mucosal response

  2012cites this paper
• CpG DNA in the Prevention and Treatment of Infections

  2012cites this paper
• Novel vaccine development strategies for inducing mucosal immunity

  2012cites this paper
• TLR-based immune adjuvants.

  2011cites this paper
• Progress Towards a Needle-Free Hepatitis B Vaccine

  2011cites this paper
• T Helper Cytokine Responses Induced by Nasal Immunization with Glucosyltransferase-I of Streptococcus sobrinus

  2011cites this paper
• Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus.

  2011cites this paper
• This information is current as Aged Mice in Streptococcus pneumoniae Immunity to Adjuvant Elicits Protective Secretory-IgA CpG Oligodeoxynucleotide as Nasal A Combination of Flt 3 Ligand cDNA and

  2011cites this paper
• Studies on the development of a Bacillus endospore-based microparticle vaccine platform

  2011cites this paper
• A Combination of Flt3 Ligand cDNA and CpG Oligodeoxynucleotide as Nasal Adjuvant Elicits Protective Secretory-IgA Immunity to Streptococcus pneumoniae in Aged Mice

  2011cites this paper
• The involvement of NK cell activation following intranasal administration of CpG DNA lipoplex in the prevention of pulmonary metastasis and peritoneal dissemination in mice

  2011cites this paper
• Systemic and Mucosal Sites Multifaceted Immune Responses Against HIV at Immunostimulatory DNA-Based Vaccines Elicit

  2011cites this paper
• Multicomponent Vaccine Delivery Systems for Subcellular Targeting of Antigen and Molecular Adjuvant.

  2011cites this paper
• A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.

  2011cites this paper
• Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments.

  2010cites this paper
• Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice.

  2010cites this paper
• Studies on the usefulness of intranasal inactivated influenza vaccines.

  2010cites this paper
• Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.

  2010cites this paper
• Nasal Administration of Glucosyltransferase-I of Streptococcus sobrinus without Adjuvant Induces Protective Immunity

  2010cites this paper
• Nasal Delivery of Peptide and Nonpeptide Drugs

  2010cites this paper
• Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

  2010cites this paper
• Adjuvants for pandemic influenza vaccines.

  2009cites this paper
• Mucosal adjuvanticity of immunostimulatory DNA sequences

  2009influential citation
• Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.

  2009cites this paper
• Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses.

  2009cites this paper
• Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines

  2009cites this paper
• The response of human B lymphocytes to oligodeoxynucleotides

  2009cites this paper
• The role of CpG in DNA vaccines

  2009influential citation
• CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.

  2009cites this paper
• Der Effekt von immunstimulatorischer DNA und Adenosin auf die Migration und Funktion humaner plasmazytoider dendritischer Zellen

  2009cites this paper
• Rescue of B cells from apoptosis by immune stimulatory CpG DNA

  2009cites this paper
• Évaluation de stratégies pour l'optimisation d'un vaccin à ADN contre le virus de la diarrhée virale bovine (BVDV)

  2009cites this paper
• The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.

  2009cites this paper
• Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.

  2009cites this paper
• Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides.

  2009cites this paper
• Mucosal immunosenescence: new developments and vaccines to control infectious diseases.

  2009cites this paper
• Improvements in the Prevention and Treatment of Anthrax Infection

  2009cites this paper
• Vaccines against epidemic and pandemic influenza

  2008cites this paper
• CpG Used as an Adjuvant for an Adenovirus-Based Venezuelan Equine Encephalitis Virus Vaccine Increases the Immune Response to the Vector, But Not to the Transgene Product

  2008cites this paper
• Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.

  2008cites this paper